Intrapericardial left ventricular assist device for advanced heart failure

New England Journal of Medicine

Volumn 376, Issue 5, 2017, Pages 451-460

  Rogers, Joseph G ^a   Pagani, Francis D ^b   Tatooles, Antone J ^c   Bhat, Geetha ^c   Slaughter, Mark S ^f   Birks, Emma J ^f   Boyce, Steven W ^g   Najjar, Samer S ^g   Jeevanandam, Valluvan ^d   Anderson, Allen S ^e   Gregoric, Igor D ^h   Mallidi, Hari ⁱ   Leadley, Katrin ^j   Aaronson, Keith D ^b   Frazier, O H ⁱ   Milano, Carmelo A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ADVOCATE CHRIST MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^f UNIVERSITY OF LOUISVILLE   (United States)

^g Medstar Institute   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ TEXAS HEART INSTITUTE   (United States)

^j HEARTWARE INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT;

ADULT; AGED; ARTICLE; AXIAL FLOW LEFT VENTRICULAR ASSIST DEVICE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIAC RESYNCHRONIZATION THERAPY; CENTRIFUGAL FLOW LEFT VENTRICULAR ASSIST DEVICE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEVICE FAILURE; DEVICE REMOVAL; DEVICE SAFETY; DRIVELINE INFECTION; FEMALE; FUNCTIONAL STATUS; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY DYSFUNCTION; LEFT VENTRICULAR ASSIST DEVICE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RIGHT VENTRICULAR ASSIST DEVICE; SEPSIS; SURVIVAL RATE; THERAPY EFFECT; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEART ASSIST DEVICE; INTENTION TO TREAT ANALYSIS; KAPLAN MEIER METHOD; MORTALITY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; STROKE;

ADULT; AGED; DISEASE-FREE SURVIVAL; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INTENTION TO TREAT ANALYSIS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS FAILURE; QUALITY OF LIFE; STROKE;

EID: 85011931414     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1602954     Document Type: Article

References (21)

1. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation 2014; 129:399-410.
2. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-51.
3. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014; 370: 33-40.
4. Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the Heart Mate II left ventricular assist device. J Heart Lung Transplant 2014; 33: 12-22.
5. Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012; 125:3191-200.
6. Larose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the Heart Ware ventricular assist system. ASAIO J 2010; 56: 285-9.
7. Interagency Registry for Mechanically Assisted Circulatory Support. Appendix O - profiles of advanced heart failure: patient profile at time of implant. Birmingham: University of Alabama School of Medicine, 2016 (https://www.uab.edu/medicine/intermacs/appendices/app-o-5-0).
8. Wieselthaler GM, O'Driscoll G, Jansz P, Khaghani A, Strueber M. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010; 29:1218-25.
9. Slaughter MS, Pagani FD, McGee EC, et al. Heart Ware ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2013; 32:675-83.
10. Slaughter MS. Implantation of the Heart Ware left ventricular assist device. Semin Thorac Cardiovasc Surg 2011; 23: 245-7.
11. Park SJ, Milano CA, Tatooles AJ, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail 2012; 5:241-8.
12. Jorde UP, Kushwaha SS, Tatooles AJ, et al. Results of the destination therapy post-Food and Drug Administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2014; 63:1751-7.
13. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885-96.
14. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009; 54:312-21.
15. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 57:1890-8.
16. Teuteberg JJ, Slaughter MS, Rogers JG, et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Heart Fail 2015; 3: 818-28.
17. Najjar SS, Slaughter MS, Pagani FD, et al. An analysis of pump thrombus events in patients in the Heart Ware ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 2014; 33:23-34.
18. Interagency Registry for Mechanically Assisted Circulatory Support. Appendix A - adverse event definitions. Birmingham: University of Alabama School of Medicine, 2013 (https://www.uab.edu/medicine/intermacs/protocol-3-0-archive-pedimacs1/appendices-pedimacs/appendix-a-pedimacs).
19. Smedira NG, Blackstone EH, Ehrlinger J, et al. Current risks of Heart Mate II pump thrombosis: non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data. J Heart Lung Transplant 2015; 34: 1527-34.
20. Kirklin JK, Naftel DC, Pagani FD, et al. Pump thrombosis in the Thoratec Heart Mate II device: an update analysis of the INTERMACS Registry. J Heart Lung Transplant 2015; 34:1515-26.
21. Jeffries N, Miller MA, Taddei-Peters WC, Burke C, Baldwin JT, Young JB. What is the truth behind pump thrombosis in the Heart Mate II device? A National Heart, Lung, and Blood Institute perspective based on data from the Interagency Registry for Mechanically Assisted Circulatory Support. J Heart Lung Transplant 2015; 34:1505-10.